title: Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase.
abstract: Endothelial nitric oxide synthase (eNOS) plays a crucial role in the regulation of a variety of cardiovascular functions. Many studies have shown that dietary n-3 polyunsaturated fatty acids (PUFAs) have beneficial effects on coronary atherosclerosis. However, the mechanisms of n-3 PUFAs regulation in eNOS activation remain unknown. In the present study we investigated the effects of eicosapentaenoic acid (EPA, 20:5 n-3) on subcellular distribution of eNOS and lipid composition of caveolae. We demonstrated for the first time that EPA treatment profoundly altered lipid composition and fatty acyl substitutions of phospholipids in caveolae. We found that caveolin-1 was solely located in caveolae fractions in control cells, and EPA treatment displaced caveolin-1 from caveolae. eNOS was detected in the caveolin-enriched fractions and noncaveolae fractions in control cells. EPA treatment induced the translocation of eNOS from caveolae fractions to soluble fractions. P-eNOS was also distributed in both fractions. After EPA treatment, the level of p-eNOS in each fraction was increased but the distribution of which was unaffected. Moreover, the results of immunofluorescence confirmed that EPA could redistribute caveolin-1 and eNOS in plasma membrane. eNOS activity in HUVEC cells was increased after EPA treatment, which was in a dose dependent manner. And incubation with 50 microM EPA had the maximum effect on eNOS activity. Our results suggested that eNOS translocation was paralleled by a stimulated capacity for NO production in the cells. We found that total Akt and p-Akt were primarily presented in heavy membranes in control cells, and the relative level of p-Akt increased but the distribution did not change after EPA treatment. The distribution of CaM was slightly changed after EPA treatment. Our results indicated that n-3 PUFAs profoundly altered caveolae microenvironment, thereby modifying location and function of proteins in caveolae. EPA-induced alterations of lipid and proteins in caveolae may be an important mechanism in the pathophysiologic process of atherosclerosis.
authors.affiliation: Institute of General Surgery, Jinling Hospital, No. 305 East Zhongshan Road, Nanjing 210002, China.
authors.forename: Qiurong
authors.initials: Q
authors.lastname: Li
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhang
authors.forename: Meng
authors.initials: M
authors.lastname: Wang
authors.forename: Sumin
authors.initials: S
authors.lastname: Zhao
authors.forename: Jian
authors.initials: J
authors.lastname: Ma
authors.forename: Nan
authors.initials: N
authors.lastname: Luo
authors.forename: Ning
authors.initials: N
authors.lastname: Li
authors.forename: Yousheng
authors.initials: Y
authors.lastname: Li
authors.forename: Guowang
authors.initials: G
authors.lastname: Xu
authors.forename: Jieshou
authors.initials: J
authors.lastname: Li
mesh_terms: D015153:Blotting, Western; D021941:Caveolae / Q000737:chemistry / Q000378:metabolism*; D015118:Eicosapentaenoic Acid / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D006801:Humans; D013058:Mass Spectrometry; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D021381:Protein Transport
chemical_list: D005227:Fatty Acids; D015118:Eicosapentaenoic Acid; D052250:Nitric Oxide Synthase Type III